About Arkuda Therapeutics
Leveraging new insights into progranulin and lysosomal biology to discover therapies to change the trajectory of neurodegenerative disease.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-B+
Global Headquarters
Watertown, United States
Year Founded
2023
Team Size
11-50
Tracked Since
Oct 1, 2026
Web & Domain Identity
Official Website
Not publicly listed
Domain Registered Date
Feb 20, 2018
Social & Network Presence
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Milestone
Company founded
Watertown, United States
- Capital Raise
Raised $64,000,000 · Series-B+
fundraisingfox.com
- Capital Raise
Raised $44,000,000 · Series-A
- Milestone
X account created (@ArkudaTx)
240 followers
- Milestone
Website domain registered
Investors & Backers
Atlas Venture
Cormorant Asset Management
Eli Lilly
Michael J. Fox Foundation
Mission BioCapital
Pfizer Venture Investments
Pivotal bioVenture Partners
Surveyor Capital
Tekla Capital Management
Funding History
Series-B+
· Feb 10, 2022
$64,000,000 fundraisingfox.com
Series-A
· Nov 7, 2019
$44,000,000 Source
Founders & Leadership
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026